{"gene":"GABRP","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":2019,"finding":"GABRP interacts physically with KCNN4 (a calcium-activated potassium channel) to induce Ca2+ entry in pancreatic cancer cells, independent of GABA neurotransmitter signaling. This Ca2+ influx activates NF-κB signaling, which drives CXCL5 and CCL20 expression to recruit macrophages and promote tumor progression.","method":"Co-immunoprecipitation, proximity ligation assay, electrophysiology, promoter luciferase activity assays, ELISA, xenograft and orthotopic models, macrophage depletion experiments","journal":"Gut","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and proximity ligation assay to confirm GABRP-KCNN4 interaction, electrophysiology to confirm Ca2+ entry, luciferase for pathway activation, in vivo rescue by macrophage depletion; multiple orthogonal methods in a single rigorous study","pmids":["30826748"],"is_preprint":false},{"year":2014,"finding":"GABRP promotes migration of basal-like breast cancer cells through activation of ERK1/2 phosphorylation, which sustains expression of basal-like cytokeratins (KRT5, KRT6B, KRT14, KRT17) and cellular protrusions. Stable GABRP silencing reduced ERK1/2 phosphorylation, cytokeratin expression, and migration; selective ERK1/2 inhibition phenocopied this effect.","method":"Stable shRNA knockdown in HCC1187 and HCC70 BLBC cell lines, western blot for phospho-ERK1/2, selective ERK1/2 inhibitor treatment, migration assays, cytoskeletal analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean KD with defined phenotype confirmed by pharmacological inhibitor, two cell lines, but no reconstitution or structural data; single lab","pmids":["25012653"],"is_preprint":false},{"year":2017,"finding":"GABRP promotes ovarian cancer cell migration and invasion through activation of the MAPK/ERK pathway; GABRP overexpression increased ERK activation and migration/invasion, while GABRP knockdown reduced these, and MEK inhibitor U0126 phenocopied knockdown. Epigenetic regulation of GABRP expression occurs via DNA methylation at the -963 CpG site in the GABRP promoter.","method":"GABRP knockdown and overexpression in SK-OV-3 cells, MEK inhibitor treatment, migration/invasion assays, western blot for ERK, genome-wide DNA methylation profiling, DNA methyltransferase inhibitor treatment","journal":"Experimental & molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function and loss-of-function with pharmacological inhibitor phenocopy, orthogonal methylation profiling; single lab","pmids":["28524180"],"is_preprint":false},{"year":2021,"finding":"GABRP interacts with EGFR as a membrane protein in triple-negative breast cancer stem cells, sustaining EGFR expression and downstream signaling to maintain cancer stem cell properties (stemness) and confer chemotherapy resistance. Silencing GABRP downregulates EGFR signaling, reduces stemness, and increases sensitivity to paclitaxel, doxorubicin, and cisplatin.","method":"Co-immunoprecipitation (GABRP-EGFR interaction), GABRP knockdown and overexpression, stemness assays, drug sensitivity assays, western blot for EGFR pathway components","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP to establish GABRP-EGFR interaction, loss-of-function with multiple functional readouts including drug sensitivity; single lab","pmids":["34023418"],"is_preprint":false},{"year":2023,"finding":"GABRP promotes pancreatic cancer cell invasion, migration, EMT, and tumor growth via activation of the MEK/ERK signaling pathway. Knockdown of GABRP suppressed MEK/ERK pathway activity and these behaviors; GABRP overexpression facilitated them; pharmacological inactivation of MEK/ERK reversed the effects of GABRP overexpression.","method":"GABRP knockdown and overexpression in pancreatic cancer cells, Transwell invasion/migration assays, western blot for MEK/ERK pathway, MEK/ERK inhibitor treatment, xenograft tumor growth assay","journal":"Biochemical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — bidirectional genetic manipulation with pharmacological rescue epistasis; single lab, no structural or biochemical reconstitution","pmids":["37326897"],"is_preprint":false},{"year":2021,"finding":"Gabrp is highly expressed in mouse Club (airway epithelial progenitor) cells and is required for their proliferation and differentiation into goblet cells. Pharmacological blockade of Gabrp with bicuculline methiodide (BMI) in organoid cultures reduced organoid-forming ability and decreased mRNA levels of Clca3p, Muc5Ac, and Muc5B (goblet cell markers), indicating Gabrp mediates GABA signaling for this differentiation program.","method":"Naphthalene-induced Club cell injury model in mice, organoid cultures with GABRP antagonist (BMI), RT-qPCR for differentiation markers","journal":"Experimental and therapeutic medicine","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological blockade in organoid cultures, RT-qPCR readout; single lab, single method per conclusion","pmids":["34007329"],"is_preprint":false},{"year":2020,"finding":"miR-320c directly targets GABRP mRNA and suppresses cervical cancer cell migration; overexpression of GABRP reversed the anti-migratory effect of miR-320c, establishing GABRP as a functional downstream target of miR-320c in cervical cancer cell migration.","method":"miR-320c overexpression, GABRP rescue experiments, migration assays in HeLa and C33-A cells, online target prediction validated functionally","journal":"European review for medical and pharmacological sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — functional rescue experiment to confirm target relationship, but no direct 3'UTR reporter validation described in abstract; single lab","pmids":["32964961"],"is_preprint":false},{"year":2022,"finding":"GABRP acts downstream of CD44s in pancreatic cancer cells to mediate gemcitabine resistance; CD44 knockdown decreased GABRP mRNA, and long-term gemcitabine-resistant cells showed co-upregulation of CD44 and GABRP, placing GABRP as a CD44s downstream effector in chemoresistance.","method":"shRNA-mediated CD44 knockdown, CD44s overexpression, cell viability and colony formation assays, RT-qPCR, western blot in pancreatic cancer cell lines","journal":"PeerJ","confidence":"Low","confidence_rationale":"Tier 3 / Weak — genetic manipulation of upstream regulator with downstream expression readout; pathway placement is indirect (no direct GABRP rescue to confirm epistasis); single lab","pmids":["35846884"],"is_preprint":false}],"current_model":"GABRP (GABAA receptor π subunit) functions as a membrane-associated signaling protein in cancer and non-neuronal tissues through both GABA-dependent and GABA-independent mechanisms: in pancreatic cancer it physically interacts with KCNN4 to drive Ca2+ entry and NF-κB-mediated chemokine secretion independent of GABA, while in breast and other cancers it activates ERK/MAPK signaling and interacts with EGFR to sustain stemness and chemoresistance; in airway epithelium it mediates GABA signaling required for Club cell differentiation into goblet cells."},"narrative":{"mechanistic_narrative":"GABRP, the GABAA receptor π subunit, functions as a membrane-associated driver of malignant cell behavior across multiple non-neuronal cancers, acting through both GABA-independent and GABA-dependent mechanisms [PMID:30826748, PMID:25012653]. In pancreatic cancer it physically associates with the calcium-activated potassium channel KCNN4 to trigger Ca2+ entry independent of GABA neurotransmitter signaling, activating NF-κB to induce CXCL5 and CCL20 expression that recruits macrophages and promotes tumor progression [PMID:30826748]. A second, recurrent mechanism is activation of MEK/ERK signaling: GABRP sustains ERK1/2 phosphorylation to drive migration, invasion, and EMT in basal-like breast, ovarian, and pancreatic cancer cells, with pharmacological MEK/ERK inhibition phenocopying GABRP loss in each setting [PMID:25012653, PMID:28524180, PMID:37326897]. In triple-negative breast cancer stem cells GABRP interacts with EGFR to sustain EGFR signaling, maintaining stemness and conferring resistance to paclitaxel, doxorubicin, and cisplatin [PMID:34023418]. GABRP expression is itself controlled by promoter DNA methylation [PMID:28524180] and by upstream regulators including miR-320c and CD44s [PMID:32964961, PMID:35846884]. Beyond cancer, GABRP mediates GABA signaling required for airway Club cell proliferation and differentiation into goblet cells [PMID:34007329]. No structural or reconstituted biochemical mechanism for these interactions has been characterized in the available corpus.","teleology":[{"year":2014,"claim":"Established that GABRP drives a malignant phenotype through intracellular kinase signaling rather than canonical neurotransmission, linking it to ERK1/2 activation and basal-like cytokeratin expression in breast cancer.","evidence":"Stable shRNA knockdown in two BLBC cell lines with phospho-ERK1/2 western blot, selective ERK1/2 inhibitor phenocopy, and migration assays","pmids":["25012653"],"confidence":"Medium","gaps":["No reconstitution or direct demonstration of how GABRP couples to ERK1/2","Single lab, no in vivo validation","Mechanism of ERK activation upstream of phosphorylation undefined"]},{"year":2017,"claim":"Generalized the GABRP–MAPK/ERK axis to ovarian cancer and identified promoter DNA methylation as a control mechanism for GABRP expression.","evidence":"Knockdown and overexpression in SK-OV-3 cells with MEK inhibitor U0126 phenocopy, migration/invasion assays, and genome-wide methylation profiling","pmids":["28524180"],"confidence":"Medium","gaps":["No biochemical link between GABRP and the MEK/ERK cascade","Single cell line for functional readouts","Causal demonstration that -963 CpG methylation governs phenotype not shown"]},{"year":2019,"claim":"Defined a GABA-independent mechanism in which GABRP physically partners with KCNN4 to drive Ca2+/NF-κB signaling and remodel the tumor immune microenvironment, distinguishing it from classical receptor function.","evidence":"Reciprocal Co-IP and proximity ligation assay, electrophysiology, promoter luciferase, ELISA, and xenograft/orthotopic models with macrophage depletion","pmids":["30826748"],"confidence":"High","gaps":["Structural basis of GABRP-KCNN4 interaction unresolved","How GABRP gates Ca2+ entry mechanistically not defined","Relationship between this Ca2+/NF-κB axis and the ERK axis seen elsewhere unaddressed"]},{"year":2020,"claim":"Placed GABRP within a regulatory network as a functional downstream target of miR-320c controlling cervical cancer cell migration.","evidence":"miR-320c overexpression with GABRP rescue and migration assays in HeLa and C33-A cells","pmids":["32964961"],"confidence":"Low","gaps":["No direct 3'UTR reporter validation of targeting described","Single lab","Downstream effector mechanism of GABRP in cervical cancer not examined"]},{"year":2021,"claim":"Identified EGFR as a physical partner of GABRP in TNBC stem cells, connecting GABRP to stemness maintenance and chemoresistance.","evidence":"Co-IP for GABRP-EGFR interaction, knockdown/overexpression, stemness and drug-sensitivity assays, and EGFR-pathway western blots","pmids":["34023418"],"confidence":"Medium","gaps":["Co-IP without reciprocal or structural confirmation","Mechanism by which GABRP sustains EGFR expression unknown","Single lab"]},{"year":2021,"claim":"Demonstrated a non-malignant, GABA-dependent role for GABRP in airway epithelial Club cell proliferation and differentiation into goblet cells.","evidence":"Naphthalene injury model and organoid cultures with GABRP antagonist bicuculline methiodide, RT-qPCR for goblet markers","pmids":["34007329"],"confidence":"Low","gaps":["Pharmacological blockade only; no genetic loss-of-function","Single method per conclusion","Downstream signaling mediating differentiation not defined"]},{"year":2022,"claim":"Positioned GABRP downstream of CD44s in pancreatic cancer chemoresistance, extending its regulatory inputs.","evidence":"shRNA CD44 knockdown and CD44s overexpression with viability/colony assays and RT-qPCR/western blot in pancreatic cancer lines","pmids":["35846884"],"confidence":"Low","gaps":["No direct GABRP rescue to confirm epistasis","Pathway placement is indirect","Single lab"]},{"year":2023,"claim":"Confirmed the GABRP–MEK/ERK axis drives invasion, EMT, and tumor growth in pancreatic cancer, consolidating MAPK signaling as a recurrent GABRP effector across tumor types.","evidence":"Bidirectional knockdown/overexpression with Transwell assays, MEK/ERK western blots, pharmacological inhibitor rescue, and xenograft growth assay","pmids":["37326897"],"confidence":"Medium","gaps":["No biochemical mechanism coupling GABRP to MEK/ERK","Relationship to the GABRP-KCNN4/Ca2+ axis in the same tissue unclear","Single lab"]},{"year":null,"claim":"How GABRP, a GABAA receptor subunit, mechanistically couples to its partner channels and receptors (KCNN4, EGFR) and to the MEK/ERK cascade in the absence of canonical GABA gating remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of GABRP complexes","No reconstituted biochemical assay of GABRP signaling","Whether a single unified mechanism underlies the Ca2+, ERK, and EGFR phenotypes is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1,2,4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,3]}],"complexes":[],"partners":["KCNN4","EGFR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O00591","full_name":"Gamma-aminobutyric acid receptor subunit pi","aliases":["GABA(A) receptor subunit pi","GABAAR subunit pi"],"length_aa":440,"mass_kda":50.6,"function":"Pi subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA) (PubMed:10462548). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interfaces (By similarity). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed:10462548). Pi-containing GABAARs are mostly located in peripheral tissues. In the uterus, pi subunits modulate uterus contraction by altering the sensitivity of GABAARs to pregnanolone (PubMed:9182563). In the lungs, pi-containing GABAARs contribute to pulmonary fluid transport via luminal secretion of chloride (By similarity)","subcellular_location":"Cell membrane; Apical cell membrane","url":"https://www.uniprot.org/uniprotkb/O00591/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRP","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRP","total_profiled":1310},"omim":[{"mim_id":"602729","title":"GAMMA-AMINOBUTYRIC ACID RECEPTOR, PI; GABRP","url":"https://www.omim.org/entry/602729"},{"mim_id":"181510","title":"SCHIZOPHRENIA 1; SCZD1","url":"https://www.omim.org/entry/181510"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"breast","ntpm":142.2},{"tissue":"esophagus","ntpm":161.4}],"url":"https://www.proteinatlas.org/search/GABRP"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O00591","domains":[{"cath_id":"2.70.170.10","chopping":"43-241","consensus_level":"high","plddt":92.7656,"start":43,"end":241},{"cath_id":"1.20.58.390","chopping":"245-337_429-440","consensus_level":"high","plddt":89.2594,"start":245,"end":440}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O00591","model_url":"https://alphafold.ebi.ac.uk/files/AF-O00591-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O00591-F1-predicted_aligned_error_v6.png","plddt_mean":79.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRP","jax_strain_url":"https://www.jax.org/strain/search?query=GABRP"},"sequence":{"accession":"O00591","fasta_url":"https://rest.uniprot.org/uniprotkb/O00591.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O00591/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O00591"}},"corpus_meta":[{"pmid":"30826748","id":"PMC_30826748","title":"GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner.","date":"2019","source":"Gut","url":"https://pubmed.ncbi.nlm.nih.gov/30826748","citation_count":159,"is_preprint":false},{"pmid":"25012653","id":"PMC_25012653","title":"GABA(A) receptor pi (GABRP) stimulates basal-like breast cancer cell migration through activation of extracellular-regulated kinase 1/2 (ERK1/2).","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25012653","citation_count":84,"is_preprint":false},{"pmid":"28524180","id":"PMC_28524180","title":"Aberrant epigenetic regulation of GABRP associates with aggressive phenotype of ovarian cancer.","date":"2017","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28524180","citation_count":50,"is_preprint":false},{"pmid":"34023418","id":"PMC_34023418","title":"GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling.","date":"2021","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/34023418","citation_count":37,"is_preprint":false},{"pmid":"32359161","id":"PMC_32359161","title":"Use of a human embryonic stem cell model to discover GABRP, WFDC2, VTCN1 and ACTC1 as markers of early first trimester human trophoblast.","date":"2020","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/32359161","citation_count":37,"is_preprint":false},{"pmid":"16187283","id":"PMC_16187283","title":"Systematic characterisation of GABRP expression in sporadic breast cancer and normal breast tissue.","date":"2006","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/16187283","citation_count":34,"is_preprint":false},{"pmid":"34007329","id":"PMC_34007329","title":"Inhibition of Gabrp reduces the differentiation of airway epithelial progenitor cells into goblet cells.","date":"2021","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34007329","citation_count":11,"is_preprint":false},{"pmid":"32964961","id":"PMC_32964961","title":"MiR-320c prevents the malignant development of cervical cancer by regulating GABRP level.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32964961","citation_count":9,"is_preprint":false},{"pmid":"36747550","id":"PMC_36747550","title":"Elevated GABRP expression is correlated to the excessive autophagy in intrahepatic cholestasis of pregnancy.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/36747550","citation_count":8,"is_preprint":false},{"pmid":"35846884","id":"PMC_35846884","title":"GABRP promotes CD44s-mediated gemcitabine resistance in pancreatic cancer.","date":"2022","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/35846884","citation_count":7,"is_preprint":false},{"pmid":"37326897","id":"PMC_37326897","title":"GABRP Promotes the Metastasis of Pancreatic Cancer by Activation of the MEK/ERK Signaling Pathway.","date":"2023","source":"Biochemical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37326897","citation_count":7,"is_preprint":false},{"pmid":"26634217","id":"PMC_26634217","title":"The Association of the GABRP Polymorphisms with Systemic Lupus Erythematosus.","date":"2015","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/26634217","citation_count":6,"is_preprint":false},{"pmid":"36230278","id":"PMC_36230278","title":"Maternal Dietary Supplementation with γ-Aminobutyric Acid Alleviated Oxidative Stress in Gestating Sows and Their Offspring by Regulating GABRP.","date":"2022","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/36230278","citation_count":5,"is_preprint":false},{"pmid":"40459297","id":"PMC_40459297","title":"GABRP Mediates GABA-A Receptor to Shape Tumor Immunosuppressive Microenvironment and Promote Tumor Immune Escape and Corresponding Targeted Therapy.","date":"2025","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/40459297","citation_count":2,"is_preprint":false},{"pmid":"38197563","id":"PMC_38197563","title":"High glucose regulates the cells dysfunction of human trophoblast HTR8/SVneo cells by downregulating GABRP expression.","date":"2024","source":"Advances in clinical and experimental medicine : official organ Wroclaw Medical University","url":"https://pubmed.ncbi.nlm.nih.gov/38197563","citation_count":2,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":10298,"output_tokens":2270,"usd":0.032472,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9366,"output_tokens":2947,"usd":0.060253,"stage2_stop_reason":"end_turn"},"total_usd":0.092725,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"GABRP interacts physically with KCNN4 (a calcium-activated potassium channel) to induce Ca2+ entry in pancreatic cancer cells, independent of GABA neurotransmitter signaling. This Ca2+ influx activates NF-κB signaling, which drives CXCL5 and CCL20 expression to recruit macrophages and promote tumor progression.\",\n      \"method\": \"Co-immunoprecipitation, proximity ligation assay, electrophysiology, promoter luciferase activity assays, ELISA, xenograft and orthotopic models, macrophage depletion experiments\",\n      \"journal\": \"Gut\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and proximity ligation assay to confirm GABRP-KCNN4 interaction, electrophysiology to confirm Ca2+ entry, luciferase for pathway activation, in vivo rescue by macrophage depletion; multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"30826748\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GABRP promotes migration of basal-like breast cancer cells through activation of ERK1/2 phosphorylation, which sustains expression of basal-like cytokeratins (KRT5, KRT6B, KRT14, KRT17) and cellular protrusions. Stable GABRP silencing reduced ERK1/2 phosphorylation, cytokeratin expression, and migration; selective ERK1/2 inhibition phenocopied this effect.\",\n      \"method\": \"Stable shRNA knockdown in HCC1187 and HCC70 BLBC cell lines, western blot for phospho-ERK1/2, selective ERK1/2 inhibitor treatment, migration assays, cytoskeletal analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD with defined phenotype confirmed by pharmacological inhibitor, two cell lines, but no reconstitution or structural data; single lab\",\n      \"pmids\": [\"25012653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GABRP promotes ovarian cancer cell migration and invasion through activation of the MAPK/ERK pathway; GABRP overexpression increased ERK activation and migration/invasion, while GABRP knockdown reduced these, and MEK inhibitor U0126 phenocopied knockdown. Epigenetic regulation of GABRP expression occurs via DNA methylation at the -963 CpG site in the GABRP promoter.\",\n      \"method\": \"GABRP knockdown and overexpression in SK-OV-3 cells, MEK inhibitor treatment, migration/invasion assays, western blot for ERK, genome-wide DNA methylation profiling, DNA methyltransferase inhibitor treatment\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function and loss-of-function with pharmacological inhibitor phenocopy, orthogonal methylation profiling; single lab\",\n      \"pmids\": [\"28524180\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GABRP interacts with EGFR as a membrane protein in triple-negative breast cancer stem cells, sustaining EGFR expression and downstream signaling to maintain cancer stem cell properties (stemness) and confer chemotherapy resistance. Silencing GABRP downregulates EGFR signaling, reduces stemness, and increases sensitivity to paclitaxel, doxorubicin, and cisplatin.\",\n      \"method\": \"Co-immunoprecipitation (GABRP-EGFR interaction), GABRP knockdown and overexpression, stemness assays, drug sensitivity assays, western blot for EGFR pathway components\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP to establish GABRP-EGFR interaction, loss-of-function with multiple functional readouts including drug sensitivity; single lab\",\n      \"pmids\": [\"34023418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GABRP promotes pancreatic cancer cell invasion, migration, EMT, and tumor growth via activation of the MEK/ERK signaling pathway. Knockdown of GABRP suppressed MEK/ERK pathway activity and these behaviors; GABRP overexpression facilitated them; pharmacological inactivation of MEK/ERK reversed the effects of GABRP overexpression.\",\n      \"method\": \"GABRP knockdown and overexpression in pancreatic cancer cells, Transwell invasion/migration assays, western blot for MEK/ERK pathway, MEK/ERK inhibitor treatment, xenograft tumor growth assay\",\n      \"journal\": \"Biochemical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional genetic manipulation with pharmacological rescue epistasis; single lab, no structural or biochemical reconstitution\",\n      \"pmids\": [\"37326897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Gabrp is highly expressed in mouse Club (airway epithelial progenitor) cells and is required for their proliferation and differentiation into goblet cells. Pharmacological blockade of Gabrp with bicuculline methiodide (BMI) in organoid cultures reduced organoid-forming ability and decreased mRNA levels of Clca3p, Muc5Ac, and Muc5B (goblet cell markers), indicating Gabrp mediates GABA signaling for this differentiation program.\",\n      \"method\": \"Naphthalene-induced Club cell injury model in mice, organoid cultures with GABRP antagonist (BMI), RT-qPCR for differentiation markers\",\n      \"journal\": \"Experimental and therapeutic medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological blockade in organoid cultures, RT-qPCR readout; single lab, single method per conclusion\",\n      \"pmids\": [\"34007329\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"miR-320c directly targets GABRP mRNA and suppresses cervical cancer cell migration; overexpression of GABRP reversed the anti-migratory effect of miR-320c, establishing GABRP as a functional downstream target of miR-320c in cervical cancer cell migration.\",\n      \"method\": \"miR-320c overexpression, GABRP rescue experiments, migration assays in HeLa and C33-A cells, online target prediction validated functionally\",\n      \"journal\": \"European review for medical and pharmacological sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — functional rescue experiment to confirm target relationship, but no direct 3'UTR reporter validation described in abstract; single lab\",\n      \"pmids\": [\"32964961\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GABRP acts downstream of CD44s in pancreatic cancer cells to mediate gemcitabine resistance; CD44 knockdown decreased GABRP mRNA, and long-term gemcitabine-resistant cells showed co-upregulation of CD44 and GABRP, placing GABRP as a CD44s downstream effector in chemoresistance.\",\n      \"method\": \"shRNA-mediated CD44 knockdown, CD44s overexpression, cell viability and colony formation assays, RT-qPCR, western blot in pancreatic cancer cell lines\",\n      \"journal\": \"PeerJ\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — genetic manipulation of upstream regulator with downstream expression readout; pathway placement is indirect (no direct GABRP rescue to confirm epistasis); single lab\",\n      \"pmids\": [\"35846884\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRP (GABAA receptor π subunit) functions as a membrane-associated signaling protein in cancer and non-neuronal tissues through both GABA-dependent and GABA-independent mechanisms: in pancreatic cancer it physically interacts with KCNN4 to drive Ca2+ entry and NF-κB-mediated chemokine secretion independent of GABA, while in breast and other cancers it activates ERK/MAPK signaling and interacts with EGFR to sustain stemness and chemoresistance; in airway epithelium it mediates GABA signaling required for Club cell differentiation into goblet cells.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GABRP, the GABAA receptor π subunit, functions as a membrane-associated driver of malignant cell behavior across multiple non-neuronal cancers, acting through both GABA-independent and GABA-dependent mechanisms [#0, #1]. In pancreatic cancer it physically associates with the calcium-activated potassium channel KCNN4 to trigger Ca2+ entry independent of GABA neurotransmitter signaling, activating NF-κB to induce CXCL5 and CCL20 expression that recruits macrophages and promotes tumor progression [#0]. A second, recurrent mechanism is activation of MEK/ERK signaling: GABRP sustains ERK1/2 phosphorylation to drive migration, invasion, and EMT in basal-like breast, ovarian, and pancreatic cancer cells, with pharmacological MEK/ERK inhibition phenocopying GABRP loss in each setting [#1, #2, #4]. In triple-negative breast cancer stem cells GABRP interacts with EGFR to sustain EGFR signaling, maintaining stemness and conferring resistance to paclitaxel, doxorubicin, and cisplatin [#3]. GABRP expression is itself controlled by promoter DNA methylation [#2] and by upstream regulators including miR-320c and CD44s [#6, #7]. Beyond cancer, GABRP mediates GABA signaling required for airway Club cell proliferation and differentiation into goblet cells [#5]. No structural or reconstituted biochemical mechanism for these interactions has been characterized in the available corpus.\",\n  \"teleology\": [\n    {\n      \"year\": 2014,\n      \"claim\": \"Established that GABRP drives a malignant phenotype through intracellular kinase signaling rather than canonical neurotransmission, linking it to ERK1/2 activation and basal-like cytokeratin expression in breast cancer.\",\n      \"evidence\": \"Stable shRNA knockdown in two BLBC cell lines with phospho-ERK1/2 western blot, selective ERK1/2 inhibitor phenocopy, and migration assays\",\n      \"pmids\": [\"25012653\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reconstitution or direct demonstration of how GABRP couples to ERK1/2\", \"Single lab, no in vivo validation\", \"Mechanism of ERK activation upstream of phosphorylation undefined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Generalized the GABRP–MAPK/ERK axis to ovarian cancer and identified promoter DNA methylation as a control mechanism for GABRP expression.\",\n      \"evidence\": \"Knockdown and overexpression in SK-OV-3 cells with MEK inhibitor U0126 phenocopy, migration/invasion assays, and genome-wide methylation profiling\",\n      \"pmids\": [\"28524180\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical link between GABRP and the MEK/ERK cascade\", \"Single cell line for functional readouts\", \"Causal demonstration that -963 CpG methylation governs phenotype not shown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined a GABA-independent mechanism in which GABRP physically partners with KCNN4 to drive Ca2+/NF-κB signaling and remodel the tumor immune microenvironment, distinguishing it from classical receptor function.\",\n      \"evidence\": \"Reciprocal Co-IP and proximity ligation assay, electrophysiology, promoter luciferase, ELISA, and xenograft/orthotopic models with macrophage depletion\",\n      \"pmids\": [\"30826748\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of GABRP-KCNN4 interaction unresolved\", \"How GABRP gates Ca2+ entry mechanistically not defined\", \"Relationship between this Ca2+/NF-κB axis and the ERK axis seen elsewhere unaddressed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed GABRP within a regulatory network as a functional downstream target of miR-320c controlling cervical cancer cell migration.\",\n      \"evidence\": \"miR-320c overexpression with GABRP rescue and migration assays in HeLa and C33-A cells\",\n      \"pmids\": [\"32964961\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct 3'UTR reporter validation of targeting described\", \"Single lab\", \"Downstream effector mechanism of GABRP in cervical cancer not examined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified EGFR as a physical partner of GABRP in TNBC stem cells, connecting GABRP to stemness maintenance and chemoresistance.\",\n      \"evidence\": \"Co-IP for GABRP-EGFR interaction, knockdown/overexpression, stemness and drug-sensitivity assays, and EGFR-pathway western blots\",\n      \"pmids\": [\"34023418\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Co-IP without reciprocal or structural confirmation\", \"Mechanism by which GABRP sustains EGFR expression unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Demonstrated a non-malignant, GABA-dependent role for GABRP in airway epithelial Club cell proliferation and differentiation into goblet cells.\",\n      \"evidence\": \"Naphthalene injury model and organoid cultures with GABRP antagonist bicuculline methiodide, RT-qPCR for goblet markers\",\n      \"pmids\": [\"34007329\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Pharmacological blockade only; no genetic loss-of-function\", \"Single method per conclusion\", \"Downstream signaling mediating differentiation not defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Positioned GABRP downstream of CD44s in pancreatic cancer chemoresistance, extending its regulatory inputs.\",\n      \"evidence\": \"shRNA CD44 knockdown and CD44s overexpression with viability/colony assays and RT-qPCR/western blot in pancreatic cancer lines\",\n      \"pmids\": [\"35846884\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct GABRP rescue to confirm epistasis\", \"Pathway placement is indirect\", \"Single lab\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Confirmed the GABRP–MEK/ERK axis drives invasion, EMT, and tumor growth in pancreatic cancer, consolidating MAPK signaling as a recurrent GABRP effector across tumor types.\",\n      \"evidence\": \"Bidirectional knockdown/overexpression with Transwell assays, MEK/ERK western blots, pharmacological inhibitor rescue, and xenograft growth assay\",\n      \"pmids\": [\"37326897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No biochemical mechanism coupling GABRP to MEK/ERK\", \"Relationship to the GABRP-KCNN4/Ca2+ axis in the same tissue unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How GABRP, a GABAA receptor subunit, mechanistically couples to its partner channels and receptors (KCNN4, EGFR) and to the MEK/ERK cascade in the absence of canonical GABA gating remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of GABRP complexes\", \"No reconstituted biochemical assay of GABRP signaling\", \"Whether a single unified mechanism underlies the Ca2+, ERK, and EGFR phenotypes is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"KCNN4\", \"EGFR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":6,"faith_total":6,"faith_pct":100.0}}